Company Profile

Company Overview

Roswell Park is the only National Cancer Institute (NCI) designated Comprehensive Cancer Center in Upstate New York, consistently ranks among the NCI’s top recipients of research funding and has been recognized by US News & World Report – Best Hospitals for Cancer for many years, ranking #14 on the list in both 2019 and 2020. Over the last decade, Roswell Park has undergone significant growth, adding over 1,500 new jobs, initiating one of the nation’s first hospital facilities dedicated to Phase I cancer research studies, and setting itself apart as a leader in surgical robotics, vitamin D research, immunotherapy and vaccine therapy, personalized medicine, studies targeting tumor microenvironment and cancer prevention, and the development and testing of new agents and technology. Committing the infrastructure, intellectual capital and necessary resources to convert its scientific discoveries into products and applications to help cancer patients, Roswell Park has established several biotech spin-off companies and formed strategic partnerships with investigators and centers throughout the world.

Roswell Park’s main campus spans 29 acres in downtown Buffalo and consists of 15 buildings, housing a large surgical, inpatient and outpatient operation operated by an employed faculty of nationally known oncology physicians, cutting edge research facilities manned by a science faculty of over 150 members, as well as academic facilities for its accomplished education mission. In addition, the organization built a new medical research complex and renovated existing education and research space to support its future growth and expansion. The latest addition to the campus is the new 150,000 square foot Clinical Sciences Center, opened in 2019. Roswell Park maintains suburban locations both north and south of the downtown campus and has developed a significant network of hospital system affiliates across Western and Central New York State.